CD4+ T cell lineage commitment was found to be more pronounced in tumour-infiltrating lymphocytes (TILs) compared to PBMC and regional lymph nodes, indicating that differences in the tissue environments have a significant impact on CD4+ T cell destiny. The gene discussed is CD4; the disease is neoplasm.